RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Corewell Health Ventures
C

Corewell Health Ventures portfolio

Corewell Health Ventures has 1 portfolio company on record at Recent Funding.

Type: Corporate venture.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Rounds led: 1 of 1.
Capital in their rounds: $8M.
Latest deal: Rad AI · May 1, 2025.
About this page

It is a corporate venture investor based in Grand Rapids, US, founded in 2017. Its most recent investment on record is Rad AI's $8M Series B+ round in May 2025, which it led, alongside Memorial Hermann Health System, Atlantic Health System, Advocate Health and 1 other. That company is in Health and bio.

About Corewell Health Ventures

Firm type: Corporate venture.
Headquarters: Grand Rapids, US.
Founded: 2017.
Stages: Series B, Series C, Late Stage.
Sectors: AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices, Mental Health, Wellness & Fitness.
Portfolio companies: 109.
Exits: 2.
Rounds led: 0.

What Corewell Health Ventures invests in

How Corewell Health Ventures invests

StageDealsCapital in rounds
Series B+ 1 100%$8M

Corewell Health Ventures portfolio companies

CompanyRound with Corewell Health VenturesTotal raisedLatest raise
RRad AI
Health and bio
Series B+ · $8M · lead$155MMay 1, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Corewell Health Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Corewell Health Ventures, which is a subset of its real portfolio. API: /api/v1/investors/corewell-health-ventures (get a free API key). More: the most active VC firms and new venture capital funds.